Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry - PubMed (original) (raw)
. 2001 Aug 15;10(17):1729-40.
doi: 10.1093/hmg/10.17.1729.
Affiliations
- PMID: 11532982
- DOI: 10.1093/hmg/10.17.1729
Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry
J M LaSalle et al. Hum Mol Genet. 2001.
Abstract
Rett syndrome (RTT) is an X-linked, dominant neurodevelopmental disorder caused by mutations in MECP2, encoding the methyl-CpG-binding protein 2 (MeCP2). A major paradox in the pathogenesis of RTT is how mutations in ubiquitously transcribed MECP2 result in a phenotype specific to the central nervous system (CNS) during postnatal development. To address this question, we have used a novel approach for quantitating the level and distribution of wild-type and mutant MeCP2 in situ by immunofluorescence and laser scanning cytometry. Surprisingly, cellular heterogeneity in MeCP2 expression level was observed in normal brain with a subpopulation of cells exhibiting high expression (MeCP2(hi)) and the remainder exhibiting low expression (MeCP2(lo)). MeCP2 expression was significantly higher in CNS compared with non-CNS tissues of human and mouse by automated quantitation of MeCP2 on multiple tissue arrays. Quantitative localization of MeCP2 expression phenotypes in normal human brain showed a mosaic, but distinct, distribution pattern, with MeCP2(hi) neurons highest in layer IV of the cerebrum and MeCP2(lo )neurons highest in the granular layer of the cerebellum. In female RTT brains, MECP2 mutant-expressing cells were identified as cells negative for the MeCP2 C-terminal epitope. MECP2 mutant-expressing cells were randomly localized in Rett cerebrum and cerebellum and showed normal MeCP2 expression with N-terminal-specific anti-MeCP2. These results demonstrate a CNS-specific cellular phenotype of MeCP2 high expression and suggest that MECP2 mutations in RTT are only manifested in MeCP2(hi) cells. In addition, our results demonstrate the power of laser scanning cytometry in examining complex cellular phenotypes in disease pathogenesis.
Similar articles
- X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D, Simcox T, Samaco RC, LaSalle JM. Braunschweig D, et al. Hum Mol Genet. 2004 Jun 15;13(12):1275-86. doi: 10.1093/hmg/ddh142. Epub 2004 Apr 28. Hum Mol Genet. 2004. PMID: 15115765 - Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ, Akbarian S, Tudor M, Jaenisch R. Chen RZ, et al. Nat Genet. 2001 Mar;27(3):327-31. doi: 10.1038/85906. Nat Genet. 2001. PMID: 11242118 - Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.
Samaco RC, Nagarajan RP, Braunschweig D, LaSalle JM. Samaco RC, et al. Hum Mol Genet. 2004 Mar 15;13(6):629-39. doi: 10.1093/hmg/ddh063. Epub 2004 Jan 20. Hum Mol Genet. 2004. PMID: 14734626 - Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE, Zoghbi HY. Amir RE, et al. Am J Med Genet. 2000 Summer;97(2):147-52. doi: 10.1002/1096-8628(200022)97:2<147::aid-ajmg6>3.0.co;2-o. Am J Med Genet. 2000. PMID: 11180222 Review. - Rett syndrome: the complex nature of a monogenic disease.
Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F. Renieri A, et al. J Mol Med (Berl). 2003 Jun;81(6):346-54. doi: 10.1007/s00109-003-0444-9. Epub 2003 May 16. J Mol Med (Berl). 2003. PMID: 12750821 Review.
Cited by
- Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome.
Audouard E, Khefif N, Gillet-Legrand B, Nobilleau F, Bouazizi O, Stanga S, Despres G, Alves S, Lamazière A, Cartier N, Piguet F. Audouard E, et al. Pharmaceutics. 2024 Jun 3;16(6):756. doi: 10.3390/pharmaceutics16060756. Pharmaceutics. 2024. PMID: 38931878 Free PMC article. - DNA methylation and its basic function.
Moore LD, Le T, Fan G. Moore LD, et al. Neuropsychopharmacology. 2013 Jan;38(1):23-38. doi: 10.1038/npp.2012.112. Epub 2012 Jul 11. Neuropsychopharmacology. 2013. PMID: 22781841 Free PMC article. Review. - High levels of MeCP2 depress MHC class I expression in neuronal cells.
Miralvès J, Magdeleine E, Kaddoum L, Brun H, Peries S, Joly E. Miralvès J, et al. PLoS One. 2007 Dec 26;2(12):e1354. doi: 10.1371/journal.pone.0001354. PLoS One. 2007. PMID: 18159237 Free PMC article. - Rett Syndrome: Reaching for Clinical Trials.
Pozzo-Miller L, Pati S, Percy AK. Pozzo-Miller L, et al. Neurotherapeutics. 2015 Jul;12(3):631-40. doi: 10.1007/s13311-015-0353-y. Neurotherapeutics. 2015. PMID: 25861995 Free PMC article. Review. - Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.
Skene PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP. Skene PJ, et al. Mol Cell. 2010 Feb 26;37(4):457-68. doi: 10.1016/j.molcel.2010.01.030. Mol Cell. 2010. PMID: 20188665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous